Publications

LSHTM

Found 0 results for your search. Showing 0 to 0.

No results could be found for your search.

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

Effect of COVID-19 lockdown on hospital admissions and mortality in rural KwaZulu-Natal, South Africa: interrupted time series analysis.

McIntosh, A; Bachmann, M; Siedner, MJ; Gareta, D; SEELEY, J; Herbst, K;

2021

BMJ Open, (2021).11 3 10.1136/bmjopen-2020-047961.

Trust and transparency in times of crisis: Results from an online survey during the first wave (April 2020) of the COVID-19 epidemic in the UK.

ENRIA, L; WATERLOW, N; ROGERS, NT; BRINDLE, H; LAL, S; EGGO, RM; LEES, S; ROBERTS, CH;

2021

PLoS One, (2021).16 2 10.1371/journal.pone.0239247.

Estimating the minimum number of SARS-CoV-2 infected cases needed to detect viral RNA in wastewater: To what extent of the outbreak can surveillance of wastewater tell us?.

Hong, P-Y; Rachmadi, AT; Mantilla-Calderon, D; Alkahtani, M; Bashawri, YM; Al Qarni, H; O'REILLY, KM; Zhou, J;

2021

Environmental research, (2021).195, 10.1016/j.envres.2021.110748.

Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya.

Etyang, AO; Lucinde, R; Karanja, H; Kalu, C; Mugo, D; Nyagwange, J; Gitonga, J; Tuju, J; Wanjiku, P; Karani, A; Mutua, S; Maroko, H; Nzomo, E; Maitha, E; Kamuri, E; Kaugiria, T; Weru, J; Ochola, LB; Kilimo, N; Charo, S; Emukule, N; Moracha, W; Mukabi, D; Okuku, R; Ogutu, M; ... Warimwe, GM.

2021

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (2021).74 2 10.1093/cid/ciab346.

Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries.

TORRES-RUEDA, S; SWEENEY, S; BOZZANI, F; NAYLOR, NR; BAKER, T; PEARSON, C; EGGO, R; PROCTER, SR; DAVIES, N; QUAIFE, M; Kitson, N; KEOGH-BROWN, MR; JENSEN, HT; SAADI, N; KHAN, M; Huda, M; Kairu, A; Zaidi, R; Barasa, E; JIT, M; VASSALL, A;

2021

BMJ Global Health, (2021).6 12 10.1136/bmjgh-2021-005759.

High-flow nasal cannula therapy for hypoxemic respiratory failure in patients with COVID-19.

Chavarria, AP; Lezama, ES; Navarro, MG; Vazquez, RR V; Bello, HH; Gascon, JL; Juárez, LM; Avendaño, MA; Gonzalez, LE R; Ville Benavides, R; Wyssmann, RV Á; Ortiz, BS; De la Cerda, ML R; Castañeda, LM; Martinez-Juarez, LA; Gallardo-Rincón, H; Tapia-Conyer, R;

2021

Therapeutic Advances in Infectious Disease, (2021).8, 10.1177/20499361211042959.

Strategies to reduce the risk of SARS-CoV-2 importation from international travellers: modelling estimations for the United Kingdom, July 2020.

CLIFFORD, S; QUILTY, BJ; RUSSELL, TW; LIU, Y; CHAN, Y-WD; PEARSON, CA B; EGGO, RM; Endo, A; CMMID COVID-19 Working Group,; FLASCHE, S; EDMUNDS, WJ; Centre for Mathematical Modelling of Infectious Di,;

2021

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, (2021).26 39 10.2807/1560-7917.ES.2021.26.39.2001440.

Lessons learned and lessons missed: impact of the coronavirus disease 2019 (COVID-19) pandemic on all-cause mortality in 40 industrialised countries prior to mass vaccination.

Kontis, V; Bennett, JE; Parks, RM; Rashid, T; Pearson-Stuttard, J; Asaria, P; Zhou, B; Guillot, M; Mathers, CD; Khang, Y-H; MCKEE, M; Ezzati, M;

2021

Wellcome Open Research, (2021).6, 10.12688/wellcomeopenres.17253.1.

Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases.

Trefond, L; Drumez, E; Andre, M; Costedoat-Chalumeau, N; Seror, R; Devaux, M; Dernis, E; Dieudonné, Y; El Mahou, S; Lanteri, A; Melki, I; Queyrel, V; Roumier, M; Schmidt, J; Barnetche, T; Thomas, T; Cacoub, P; Belot, A; Aumaitre, O; Richez, C; Hachulla, E; FAI2R SFR SNFMI SOFREMIP CRI IMIDIATE consortium c,;

2021

Joint bone spine, (2021).88 6 10.1016/j.jbspin.2021.105226.

Exploring the effect of ritonavir and TMC-310911 on SARS-CoV-2 and SARS-CoV main proteases: potential from a molecular perspective.

Soremekun, OS; Omolabi, KF; Adewumi, AT; Soliman, ME S;

2021

Future Science OA, (2021).7 1 10.2144/fsoa-2020-0079.